Exclusive: Lonza in talks to buy Capsugel for more than $5 billion – sources – Business Insider
Business Insider |
Exclusive: Lonza in talks to buy Capsugel for more than $5 billion – sources
Business Insider (Reuters) – Swiss pharmaceutical manufacturer Lonza Group AG is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people familiar with the matter. The deal … Exclusive: Lonza in talks to buy Capsugel for more than $5 billion – sourc…Reuters KKR Closes In on $5 Billion Deal — WSJNasdaq |